Remove Organic Chemistry Remove Pharmaceuticals Remove Protein Expression Remove Vaccine
article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

Presentations that follow include: Andres Perez Bay, PhD, Senior Staff Scientist, Oncology & Angiogenesis, Regeneron Pharmaceuticals, on: ‘A bispecific METxMET antibody-drug conjugate with cleavable linker is processed in recycling and late endosomes’.

article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

Next-generation immunotherapies The fourth track of PEGS Europe 2023 on the third day is ‘Next-generation immunotherapies’, which will feature a range of sessions made up of presentations, talks and posters which address cell-based immunotherapies, vaccines, and checkpoints and agonists.